Edesa Biotech (EDSA) Total Liabilities (2013 - 2026)
Edesa Biotech (EDSA) recorded Total Liabilities of $3.91 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 481.3% from $672,674 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Total Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech reported Total Liabilities of $1.08 million, down 41.2% from FY2024.
- Annual Total Liabilities has declined for three straight fiscal years, with a five-year compound annual growth rate of -23.6% (FY2020 to FY2025).
- Across earlier fiscal years, Total Liabilities came in at $1.83 million in FY2024 (-0.5%), $1.84 million in FY2023 (-15.7%), $2.18 million in FY2022 (+43.1%) and $1.53 million in FY2021 (-63.1%).
- The fiscal Q3 2026 figure is the highest quarterly Total Liabilities since fiscal Q3 2022.
- On a year-over-year basis, Total Liabilities rose in 1 of the last seven quarters, with growth averaging 35.2%.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 481.3% in fiscal Q3 2026, against a decline of 72.5% in fiscal Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 3.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Dec 31, 2025 | 756,163.00 |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 672,674.00 |
| Mar 31, 2025 | 914,701.00 |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | 5.70 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 1.07 Mn |
API Access
Edesa Biotech Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();